NCT06391489Active, not recruiting
HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)
Piloting A Telehealth Deliverable Self-Management and Cognitive Training Program (HOBSCOTCH, HOme Based Self-Management and COgnitive Training CHanges Lives) for People With Post Acute COVID-19 Syndrome (PACS)
Source: ClinicalTrials.gov · Last updated 20 Feb 2026
Brief summary (registry, in English)
The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with Post Acute Covid Syndrome (PACS). The main questions it aims to answer are: Can the current HOBSCOTCH program be adapted for people with PACS? Will people with PACS experience improved quality of life similar to that found in people with epilepsy after participating in the HOBSCOTCH program? Participants will be asked to: * attend nine, one-hour virtual (online and/or by telephone) HOBSCOTCH-PACS sessions with a one-on-one certified HOBSCOTCH-PACS coach * complete a brief clinical questionnaire about their diagnosis of PACS * complete seven questionnaires before and after the HOBSCOTCH-PACS sessions about their quality of life, memory and thinking processes (objective and subjective cognition), about their physical and mental health and about autonomic symptoms associated with their diagnosis of PACS * keep a short daily diary (using a smart phone app or on paper) about their PACS symptoms and use of the self-management strategies taught in the HOBSCOTCH-PACS program * complete two brief surveys to assess satisfaction with their experience after the entire HOBSCOTCH-PACS program
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 10 (actual)
- First submitted
- 25 Apr 2024
- Start date
- 14 May 2024
- Primary completion date
- Dec 2026
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06391489
What you commit to
- Study type: Interventional
- Participants enrolled: 10
- From 14 May 2024 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Significant visual impairment precluding reading or writing
- Neurodegenerative illness (i.e. dementia)
- Acute psychiatric disease
Other
- Cognitive dysfunction that precludes participation in giving informed consent
- No reliable telephone or internet access
Who the study is looking for
- Literate, English-speaking with grade 12 or equivalent in education
- Self-reported diagnosis of PACS
- Self-reported cognitive/memory difficulties
- Telephone and internet access
Age in the registry: 20 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dartmouth Hitchcock Coordinator of this site? Confirm its status | Lebanon | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.